Contineum Therapeutics, Inc. CTNM
- PIPE-791 — Idiopathic Pulmonary Fibrosis Phase 2
- PIPE-791 — Chronic Pain Phase 1
LPA1R (2 companies · 3 programs)
Companies with an active program directed at LPA1R.
Structure Therapeutics Inc. GPCR
- LTSE-2578 — Idiopathic Pulmonary Fibrosis Phase 1